We are building the smart pharma R&D lab of the future.
The first 8 years of the pharmaceutical development pipeline consists of R&D. Every year, $80b is invested into these R&D tracks globally, and this investment needs to be earned back in the last 10 - 12 years of patent lifetime. By tapping into a new source of data, we believe we can shave 10 - 20% off the R&D track, which can be added to the time on market.
We are building data acquisition lab devices to remove humans from the documentation processes in life science R&D. The data from these devices will enable automatic generation of compliance documents without any chance for human error.